Bi-steric mTORC1-selective Inhibitors activate 4EBP1 reversing MYC-induced tumorigenesis and synergize with immunotherapy

Wadie D. Mahauad-Fernandez, Yu Chi Yang, Ian Lai, Jangho Park, Lilian Yao, James W. Evans, G. Leslie Burnett, Adrian Gill, Jacqueline A. M. Smith, Mallika Singh, Dean W. Felsher